Article info
PDFBest practice
UK recommendations for HER2 assessment in breast cancer: an update
- Correspondence to Emad A Rakha, Cellular Pathology Department, School of Medicine, University of Nottingham, Nottingham, Nottinghamshire, UK; emad.rakha{at}nottingham.ac.uk
Citation
UK recommendations for HER2 assessment in breast cancer: an update
Publication history
- Received October 13, 2022
- Accepted December 9, 2022
- First published December 23, 2022.
Online issue publication
March 17, 2023
Article Versions
- Previous version (23 December 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.